Michael S. Weiss - 20 Jul 2022 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
CEO and President, Director
Signature
/s/ Michael S. Weiss
Issuer symbol
TGTX
Transactions as of
20 Jul 2022
Net transactions value
$0
Form type
4
Filing time
22 Jul 2022, 16:34:23 UTC
Previous filing
24 Jun 2022
Next filing
03 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGTX Stock Option (right to buy) Award $0 +1,900,000 $0.000000 1,900,000 20 Jul 2022 Common Stock, par value $0.001 1,900,000 $7.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of options relating to 2021 service and performance, of which 1/3 will vest on 7/20/2024, 1/3 will vest on 7/20/2025, and 1/3 will vest on 7/20/2026.